Diabetes diagnosis - now a matter of sweat and tears?

21 Jan 2020

No need to draw blood; researchers develop smart technology to diagnose diabetes and treat diabetic retinopathy.

A research team from POSTECH has developed technology that allows diagnosis of diabetes and treatment of diabetic retinopathy just by wearing ‘Smart Light-emitting diode (LED) Contact Lens.’

Diabetes diagnosis - now a matter of sweat and tears?

Professor Sei Kwang Hahn and his research team have invented a smart photonic contact lens and a wearable medical device which can diagnose diabetes and treat diabetic retinopathy. Their new research results on photonic diagnosis and photonic therapy of diabetes are published on-line in Nature Reviews Materials in collaboration with a research group led by Zhenan Bao from Department of Chemical Engineering at Stanford University and David Myung from Stanford Medicine Ophthalmology.

The smart contact lens with integrated micro-LED and photodetector can measure glucose concentration in the conjunctival blood vessels by analysing the NIR light which, in turn, helps with diabetic diagnosis.

The team applied its new smart LED contact lenses to rabbits with diabetic retinopathy disease and irradiated light repeatedly for a month. This resulted in a significant reduction of angiogenesis (production of new blood vessels) in the retina and verified clinical feasibility of the smart LED contact lens for the diabetic retinopathy therapy.

This newly developed device will allow diabetic patients to monitor their blood-sugar level in real-time; it also enables medical treatment for retinopathy which is caused by diabetic complications.

Meanwhile, Professor Hahn and his research team have also developed a smart contact lens that can diagnose diabetes by analysing glucose concentration in tears and deliver drugs to treat diabetic retinopathy. Preliminary clinical tests for the developers are expected to be done in the first half of this year.

On the basis of these results, they have also developed a smart wearable medical device that can analyse glucose concentration in sweat and they verified, which could also be clinically feasible for diabetic diagnosis. Furthermore, in conjunction with PHI Biomed, they developed a blue-tooth system that can send data wirelessly allowing patients to check their diabetic diagnosis results on their mobile phones.

Professor Hahn commented: “We developed a smart LED contact lens that can diagnose diabetes and treat diabetic retinopathy with light for the first time in the world. We are planning to commercialize these smart contact lenses and smart wearable medical devices in collaboration with Stanford Medicine.”

Read More

Related news

2020 - a year for 'big answers' rather than 'big data'

2020 - a year for 'big answers' rather than 'big data'

7 Feb 2020

Zenith Technologies CEO, Joe Haugh, takes us through how the business has evolved this year, to better meet the needs of its customers, as well as the trends they see shaping the industry through 2020 and beyond.

Read more 
Inovio and Beijing Advaccine to advance vaccine against Coronavirus

Inovio and Beijing Advaccine to advance vaccine against Coronavirus

30 Jan 2020

Agreement will facilitate clinical trial translations in China.

Read more 
AstraZeneca embarks on $1bn zero carbon strategy

AstraZeneca embarks on $1bn zero carbon strategy

24 Jan 2020

The programme will include the launch of next-generation respiratory inhalers, which will use near-zero Global Warming Potential propellants.

Read more 
2019, the year that got serialization done!

2019, the year that got serialization done!

17 Dec 2019

The past 12 months have been busy as many companies fought to comply with serialization regulations.

Read more 
Edible barcodes - it's Tru!

Edible barcodes - it's Tru!

10 Dec 2019

Smart tags on pills set to improve supply chain security and patient adherence.

Read more 
US Pharmaceutical industry continues to shine according to CPhI 2019 Annual Report

US Pharmaceutical industry continues to shine according to CPhI 2019 Annual Report

9 Dec 2019

The US pharmaceutical industry continues to lead its global peers in terms of innovation and competitiveness, while still ranking high in overall growth potential despite its mature status, according to the results of a survey of 350 global pharmaceuti...

Read more 
UK experiences a 'baby boom' of new life sciences ventures

UK experiences a 'baby boom' of new life sciences ventures

2 Dec 2019

Unprecedented levels of investment cited as a major force driving the expansion.

Read more 
UK’s life sciences sector continues to attract talent despite Brexit fear

UK’s life sciences sector continues to attract talent despite Brexit fear

26 Nov 2019

The largest area of growth has been within biotechnology companies, where job openings increased by 35%.

Read more 
Winners of the 16th Pharma Awards

Winners of the 16th Pharma Awards

11 Nov 2019

Companies and individuals from across the whole pharma supply chain recognised for their excellence and commitment.

Read more 
‘FDA should withdraw ANDAs’ says expert

‘FDA should withdraw ANDAs’ says expert

21 Oct 2019

CPhI Worldwide's Annual Report suggests repeat offenders of regulatory infringements should be barred from importing into the US.

Read more